INS and metabolic syndrome: Ben Salem et al. [15] revealed that both cynarin and chlorogenic acid are considered to be responsible for its anti-atherogenic actions (Fig. 10), studies showed that the chronic administration of acid chlorogenic improved lipid profiles and skeletal muscle glucose uptake, which in turn improved fasting glucose level, glucose tolerance insulin sensitivity and dyslipidemia in rat model.